Effect of inhaled nitric oxide in endothelin-1-induced pulmonary hypertension

Biology of the Neonate

Volumn 73, Issue 4, 1998, Pages 246-253

  Truog, William E ^a,b   Norberg, Michael ^a   Thibeauli, Donald W ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Endothelin 1; L Nitro arginine methylester; Nitric oxide; NOS; Piglet; Pulmonary hypertension

Indexed keywords

ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOACTIVE AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LUNG DISEASE; LUNG VASCULAR RESISTANCE; MALE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SWINE; SYSTEMIC VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ANIMALS; DRUG INTERACTIONS; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; HYPERTENSION, PULMONARY; LUNG; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SWINE; VASCULAR RESISTANCE;

ANIMALIA; SUS SCROFA;

EID: 6844240212     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013983     Document Type: Article

References (25)

1. Barnes P, Lih SF: Regulation of pulmonary vascular tone. Pharmacol Rev 1995;47:88-131.
2. Endo A, Shimada M, Ayusawa M, Minato M, Takahashi S, Haroda K, Masaka N, Sato K; Nitric oxide and endothelin 1 during postnatal life. Biol Neonate 1996;70:15-20.
3. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH: Elevated immunoreactive endothelin-I levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993; 123:109-114.
4. Roos CM, Rich GF, Uncles DR, Daugherty MO, Frank DU: Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs. J Appl Physiol 1994;771:51-57.
5. Russell JA, Roberts JM: Functional antagonism in rabbit pulmonary veins contracted by endothelin. Pulmon Pharmacol 1991;4:67-72.
6. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH: Randomized multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 1997,131:1-7.
7. Barefield E, Karle V, Philips JB, Carlo WA: Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996;129: 279-286.
8. Day RW, Lynch JM, White KS, Ward RM: Acute response to inhaled nitric oxide on newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996;98: 698-705.
9. Ahlborg G, Lundberg JM: Nitric oxide-endothelin-1 interaction in humans: J Appl Physiol 1997;82: 1593-1600.
10. Vosatka RJ, Kashyap S, Trifiletti RR: Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994;66:65-70.
11. Perreault T, Baribeau J: Characterization of endothelin receptors in newborn piglet lung. Am J Physiol 1995;268:L607-L614.
12. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P: Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 1990;140: 449-457.
13. Gibson RG, Berger JI, Redding GJ, Standaert TA, Mayock DE, Truog WE: Effects of nitric oxide synthase inhalation during GBS sepsis in neonatal piglets. Pediatr Res 1994;36: 776-784.
14. 2α and U46,619 on pulmonary hemodynamics in piglets. Biol Neonate 1997;71:306-316.
15. Jacob TD, Nakayama DK, Seki I, Exler R, Lancaster JR Jr, Sweetland MA, Yousem S, Simmons RL, Billiar TR, Peitzman AB: Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets. J App Physiol 1994;76:1794-1801.
16. Lindeborg DM, Kavanaugh BP, Van Meurs K, Pearl RG: Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance. J Appl Physiol 1995;78:341-348.
17. Bradley LM, Czaja JF, Goldstein RE: Circulatory effects of endothelin in newborn piglets. Am J Physiol 1990;259:H1613-H1617.
18. Wong J, Vanderford PA, Winters JW, Chang R, Soifer SJ, Fineman JR: Endothelin-I does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb. J Cardiovasc Pharmacol 1993;22: S262-S266.
19. Perreault T, De Marte J: Endothelin-1 has a dilator effect on neonatal piglet pulmonary vasculature. J Cardiovasc Pharmacol 1991;18:43-50.
20. ω-nitro-L-arginine in fetal lambs. J Appl Physiol 1992;72: 1730-1734.
21. Faltin DL, Weber A, Lacroix JS, Jorge-Costa M, Morel DR: Lung mechanics and pulmonary but not systemic vascular repsonses to ET-1 are Tx and infusion rate dependent. J Appl Physiol 1996;80:1716-1723.
22. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH: Circulatory immunoreactive endothelin-1 in children with pulmonary hypertension: Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 1993;148:519-522.
23. Malamitsi-Puchner A, Antasklis A, Economou E, Mesogitis S, Papnatanious N, Koutra N, Arvantinos S: Endothelin 1-21 plasma levels in fetuses at 18-24 weeks of gestation. J Perinat Med 1995;23:321-325.
24. Kumar P, Kazzi NJ, Shankaran S: Plasma imunoreactive endothelin-1 concentration in cord blood of normal term neonates. Am J Perinatol 1995;12:113-115.
25. Golombek SG, Pettett PG, Norberg M, Youssef J, Thibeault DW, Truog WE: Variation in immunoassays of plasma ET-1 in cord blood (abstract). Pediatr Res 1996;39:211.